{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:05:30Z","timestamp":1774314330291,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04515-8","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T14:02:50Z","timestamp":1690984970000},"page":"2413-2420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-6621","authenticated-orcid":false,"given":"Hangcheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriharsha","family":"Talluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samarpit","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimin","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali K.","family":"Ankem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"1","key":"4515_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4515_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10(5):289\u2013301. https:\/\/doi.org\/10.1038\/nrclinonc.2013.41","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"4515_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/028418602760169361","volume":"41","author":"LB Travis","year":"2002","unstructured":"Travis LB (2002) Therapy-associated solid tumors. Acta Oncol 41(4):323\u2013333. https:\/\/doi.org\/10.1080\/028418602760169361","journal-title":"Acta Oncol"},{"issue":"8","key":"4515_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","volume":"20","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MP, Weller E et al (2002) Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger. J Clin Oncol 20(8):2101\u20132108. https:\/\/doi.org\/10.1200\/JCO.2002.08.021","journal-title":"J Clin Oncol"},{"issue":"16","key":"4515_CR5","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","volume":"20","author":"GM Dores","year":"2002","unstructured":"Dores GM, Metayer C, Curtis RE et al (2002) Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years. J Clin Oncol 20(16):3484\u20133494. https:\/\/doi.org\/10.1200\/JCO.2002.09.038","journal-title":"J Clin Oncol"},{"issue":"12","key":"4515_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","volume":"25","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Gilbert ES, Dores GM et al (2007) Long-term solid cancer risk among 5-year survivors of Hodgkin\u2019s lymphoma. J Clin Oncol 25(12):1489\u20131497. https:\/\/doi.org\/10.1200\/JCO.2006.09.0936","journal-title":"J Clin Oncol"},{"issue":"18","key":"4515_CR7","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa067588","volume":"356","author":"A Pettersson","year":"2007","unstructured":"Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835\u20131841. https:\/\/doi.org\/10.1056\/NEJMoa067588","journal-title":"N Engl J Med"},{"issue":"18","key":"4515_CR8","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"LB Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97(18):1354\u20131365. https:\/\/doi.org\/10.1093\/jnci\/dji278","journal-title":"J Natl Cancer Inst"},{"issue":"679","key":"4515_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1259\/0007-1285-57-679-597","volume":"57","author":"JH Hay","year":"1984","unstructured":"Hay JH, Duncan W, Kerr GR (1984) Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol 57(679):597\u2013602. https:\/\/doi.org\/10.1259\/0007-1285-57-679-597","journal-title":"Br J Radiol"},{"issue":"14","key":"4515_CR10","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","volume":"92","author":"LB Travis","year":"2000","unstructured":"Travis LB, Andersson M, Gospodarowicz M et al (2000) Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst 92(14):1165\u20131171. https:\/\/doi.org\/10.1093\/jnci\/92.14.1165","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4515_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0959-8049(96)00458-3","volume":"33","author":"EH Wanderas","year":"1997","unstructured":"Wanderas EH, Fossa SD, Tretli S (1997) Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 33(2):253\u2013262. https:\/\/doi.org\/10.1016\/s0959-8049(96)00458-3","journal-title":"Eur J Cancer"},{"issue":"9","key":"4515_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/JCO.1993.11.9.1703","volume":"11","author":"C Bokemeyer","year":"1993","unstructured":"Bokemeyer C, Schmoll HJ (1993) Secondary neoplasms following treatment of malignant germ cell tumors. J Clin Oncol 11(9):1703\u20131709. https:\/\/doi.org\/10.1200\/JCO.1993.11.9.1703","journal-title":"J Clin Oncol"},{"issue":"28","key":"4515_CR13","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","volume":"25","author":"AW van den Belt-Dusebout","year":"2007","unstructured":"van den Belt-Dusebout AW, de Wit R, Gietema JA et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25(28):4370\u20134378. https:\/\/doi.org\/10.1200\/JCO.2006.10.5296","journal-title":"J Clin Oncol"},{"issue":"2","key":"4515_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2008.10.005","volume":"181","author":"TV Tarin","year":"2009","unstructured":"Tarin TV, Sonn G, Shinghal R (2009) Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181(2):627\u2013632. https:\/\/doi.org\/10.1016\/j.juro.2008.10.005","journal-title":"J Urol"},{"issue":"9","key":"4515_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.urolonc.2015.05.002","volume":"33","author":"SA Curreri","year":"2015","unstructured":"Curreri SA, Fung C, Beard CJ (2015) Secondary malignant neoplasms in testicular cancer survivors. Urol Oncol 33(9):392\u2013398. https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.002","journal-title":"Urol Oncol"},{"issue":"3","key":"4515_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","volume":"94","author":"LB Travis","year":"2002","unstructured":"Travis LB, Gospodarowicz M, Curtis RE et al (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin\u2019s disease. J Natl Cancer Inst 94(3):182\u2013192. https:\/\/doi.org\/10.1093\/jnci\/94.3.182","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4515_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/sj.bjc.6605325","volume":"101","author":"JL Bermejo","year":"2009","unstructured":"Bermejo JL, Sundquist J, Hemminki K (2009) Bladder cancer in cancer patients: population-based estimates from a large Swedish study. Br J Cancer 101(7):1091\u20131099. https:\/\/doi.org\/10.1038\/sj.bjc.6605325","journal-title":"Br J Cancer"},{"issue":"10","key":"4515_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1200\/JCO.2005.04.2200","volume":"24","author":"NY Mudie","year":"2006","unstructured":"Mudie NY, Swerdlow AJ, Higgins CD et al (2006) Risk of second malignancy after non-Hodgkin\u2019s lymphoma: a British Cohort Study. J Clin Oncol 24(10):1568\u20131574. https:\/\/doi.org\/10.1200\/JCO.2005.04.2200","journal-title":"J Clin Oncol"},{"issue":"31","key":"4515_CR19","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2011.34.8268","volume":"29","author":"AJ Swerdlow","year":"2011","unstructured":"Swerdlow AJ, Higgins CD, Smith P et al (2011) Second cancer risk after chemotherapy for Hodgkin\u2019s lymphoma: a collaborative British cohort study. J Clin Oncol 29(31):4096\u20134104. https:\/\/doi.org\/10.1200\/JCO.2011.34.8268","journal-title":"J Clin Oncol"},{"issue":"8763","key":"4515_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-g","volume":"338","author":"J Pedersen-Bjergaard","year":"1991","unstructured":"Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, Rorth M (1991) Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 338(8763):359\u2013363. https:\/\/doi.org\/10.1016\/0140-6736(91)90490-g","journal-title":"Lancet"},{"issue":"1","key":"4515_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/oxfordjournals.annonc.a059037","volume":"6","author":"C Boshoff","year":"1995","unstructured":"Boshoff C, Begent RH, Oliver RT et al (1995) Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 6(1):35\u201340. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059037","journal-title":"Ann Oncol"},{"issue":"3","key":"4515_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.urology.2005.03.071","volume":"66","author":"VK Gajendran","year":"2005","unstructured":"Gajendran VK, Nguyen M, Ellison LM (2005) Testicular cancer patterns in African-American men. Urology 66(3):602\u2013605. https:\/\/doi.org\/10.1016\/j.urology.2005.03.071","journal-title":"Urology"},{"issue":"4","key":"4515_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","volume":"123","author":"CY Cheah","year":"2014","unstructured":"Cheah CY, Wirth A, Seymour JF (2014) Primary testicular lymphoma. Blood 123(4):486\u2013493. https:\/\/doi.org\/10.1182\/blood-2013-10-530659","journal-title":"Blood"},{"issue":"24","key":"4515_CR24","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","volume":"24","author":"BH Bochner","year":"2006","unstructured":"International Bladder Cancer Nomogram C, Bochner BH, Kattan MW, Vora KC (2006) Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24(24):3967\u20133972. https:\/\/doi.org\/10.1200\/JCO.2005.05.3884","journal-title":"J Clin Oncol"},{"issue":"6","key":"4515_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.eururo.2014.09.019","volume":"67","author":"JA Brockman","year":"2015","unstructured":"Brockman JA, Alanee S, Vickers AJ et al (2015) Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy. Eur Urol 67(6):1160\u20131167. https:\/\/doi.org\/10.1016\/j.eururo.2014.09.019","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04515-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T21:03:49Z","timestamp":1693343029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04515-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["4515"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04515-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Human Subjects Office\/Institutional Review Board (IRB) reviewed our study. The Ethics Committee clearance was obtained. Informed consent from patients were obtained as documented from the SEER official website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals and informed consent"}}]}}